Skip to main content
. Author manuscript; available in PMC: 2010 Mar 29.
Published in final edited form as: J Thorac Cardiovasc Surg. 2009 Apr 21;137(6):1521–1529. doi: 10.1016/j.jtcvs.2008.06.049

Figure 7.

Figure 7

Total histologic scores according to aprotinin dose for the three bypass conditions. ANOVA with Bonferroni comparisons revealed no significant differences in total HS between the four groups (control and aprotinin doses) for any of the bypass conditions (25°C, 10 mL, P = .12; 34°C, 10 mL, P = .82; HCA, P = .10). Error bars denote standard deviations. NS = not significant.